Feng Y - Search Results

1

Potential utility of [⁶⁸Ga]DOTA-FAPI-04 as a broad-spectrum benign disease imaging agent-comparison with [¹⁸F]FDG and [^99mTc]MDP.

Li Y, Deng L, Feng Y, Liu L, Lv F, Qiu L. Li Y, et al. Among authors: feng y. Eur Radiol. 2023 Dec;33(12):9378-9389. doi: 10.1007/s00330-023-09952-y. Epub 2023 Jul 16. Eur Radiol. 2023. PMID: 37454338

2

Influence of Cirrhosis on ⁶⁸Ga-FAPI PET/CT in Intrahepatic Tumors.

Peng D, Cao J, Guo C, He J, Yang L, Zhang J, Yang J, Feng Y, Xu T, Chen Y. Peng D, et al. Among authors: feng y. Radiology. 2023 Jun;307(5):e222448. doi: 10.1148/radiol.222448. Epub 2023 May 23. Radiology. 2023. PMID: 37219440

3

A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma.

Guo C, Liu Y, Yang H, Xia Y, Li X, Chen L, Feng Y, Zhang Y, Chen Y, Huang Z. Guo C, et al. Among authors: feng y. Br J Radiol. 2024 Mar 28;97(1156):859-867. doi: 10.1093/bjr/tqae025. Br J Radiol. 2024. PMID: 38290775

4

Imageological/Structural Study regarding the Improved Pharmacokinetics by ⁶⁸Ga-Labeled PEGylated PSMA Multimer in Prostate Cancer.

Zhang H, Rao M, Zhao H, Ren J, Hao L, Zhong M, Chen Y, Yang X, Feng Y, Yuan G. Zhang H, et al. Among authors: feng y. Pharmaceuticals (Basel). 2023 Apr 14;16(4):589. doi: 10.3390/ph16040589. Pharmaceuticals (Basel). 2023. PMID: 37111347 Free PMC article.

5

High Affinity and FAP-Targeted Radiotracers: A Potential Design Strategy to Improve the Pharmacokinetics and Tumor Uptake for FAP Inhibitors.

Wang Y, Yuan H, Liu N, Tang S, Feng Y, Liu Y, Cai P, Xia L, Zheng W, Chen Y, Zhou Z. Wang Y, et al. Among authors: feng y. J Med Chem. 2023 Jul 13;66(13):8614-8627. doi: 10.1021/acs.jmedchem.3c00259. Epub 2023 Jun 30. J Med Chem. 2023. PMID: 37390480

6

Chronic pancreatitis: Pain and computed tomography/magnetic resonance imaging findings.

Feng Y, Song LJ, Xiao B. Feng Y, et al. World J Radiol. 2024 Mar 28;16(3):40-48. doi: 10.4329/wjr.v16.i3.40. World J Radiol. 2024. PMID: 38596170 Free PMC article. Review.

7

Improve the Biodistribution with Bulky and Lipophilic Modification Strategies on Lys-Urea-Glu-Based PSMA-Targeting Radiotracers.

Cai P, Tang S, Xia L, Wang Y, Liu Y, Feng Y, Liu N, Chen Y, Zhou Z. Cai P, et al. Among authors: feng y. Mol Pharm. 2023 Feb 6;20(2):1435-1446. doi: 10.1021/acs.molpharmaceut.2c01101. Epub 2023 Jan 25. Mol Pharm. 2023. PMID: 36696174

8

Exploring the impact of PEGylation on pharmacokinetics: a size-dependent effect of polyethylene glycol on prostate-specific membrane antigen inhibitors.

Liu Y, Xia L, Li H, Cai P, Tang S, Feng Y, Liu G, Chen Y, Liu N, Zhang W, Zhou Z. Liu Y, et al. Among authors: feng y. EJNMMI Res. 2024 Feb 7;14(1):15. doi: 10.1186/s13550-024-01071-z. EJNMMI Res. 2024. PMID: 38324095 Free PMC article.

9

Efficacy and Safety of 225 Ac-DOTATATE in the Treatment of Neuroendocrine Neoplasms With High SSTR Expression.

Yang H, Zhang Y, Li H, Zhang Y, Feng Y, Yang X, Chen Y. Yang H, et al. Among authors: feng y. Clin Nucl Med. 2024 Jun 1;49(6):505-512. doi: 10.1097/RLU.0000000000005149. Epub 2024 Mar 18. Clin Nucl Med. 2024. PMID: 38498615 Clinical Trial.

10

Azithromycin cationic non-lecithoid nano/microparticles improve bioavailability and targeting efficiency.

Zhong M, Feng Y, Liao H, Hu X, Wan S, Zhu B, Zhang M, Xiong H, Zhou Y, Zhang J. Zhong M, et al. Among authors: feng y. Pharm Res. 2014 Oct;31(10):2857-67. doi: 10.1007/s11095-014-1382-7. Epub 2014 Sep 11. Pharm Res. 2014. PMID: 25208873

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,925 results

Search Page

Filters